. Some of the factors such as escalating prevalence of vascular or non-vascular stenotic conditions and cerebral aneurysms, elevating inclination towards minimally invasive therapeutic procedures across the globe, the trend of coronary stent price slashing and increasing competitiveness of the domestic player...
-
How fast the market of your interest is growing?
Key drivers behind the growth..
-
What are your biggest Challenges?Identify the key problems.. -
What are your Revenue pockets?Areas you need to bet.. -
What are your Competitors doing?Know your competitive edge.. -
Who is your Customer?Get Their changing preferences..
what we offer
Report Store
Healthcare is an ever changing domain with an explosion in knowledge and breakthrough discoveries. Hence, it has become a major thrust area for the global giants in the pharmaceutical, biotechnology and medical devices industries and also for corporates involved in research and development of new products.
IQ4I's focus areas in Healthcare include Pharmaceuticals, biotechnology, Medical devices and Healthcare IT. Since these domains cater to humans, they are subject to stringent regulatory mechanisms requiring highly specialized skills in knowledge processing, with superior quality and adherence to global standards.
IQ4I
Latest Reports
Factors like emergence of technologically advanced stent products, persistently escalating geriatric population and the feasibility of even drug eluting stents (DES) in them and the numerous acquisitions and distribution agreements among the stent companies are further substantiating enormous growth opportunities of the market.
An increase in the adoption of minimally invasive surgeries, rapid growth in the aging population, growing number of cosmetic surgeries, the prevalence of obesity and its related surgeries, the advancement in technology, and demand for electrosurgical procedures in emerging regions are driving the growth.
Some of the factors driving the market are increase in incidence and prevalence of osteoporosis, osteoarthritis, degenerative disc disease, herniated disc, scoliosis, kyphosis, lordosis, Ankylosing spondylitis, sacroiliac joint dysfunction, and, sports injuries, trauma, or abnormal anatomical developments leading to chronic disability and increase in the aging population, technological advancement, and acquisitions.
Cell analysis is gaining importance in various fields of applications such as drug discovery, diagnosis of infectious disease, cancer research, and diagnosis of genetic diseases.
The factors such as rising incidences of respiratory diseases, rapid growth in the geriatric population requiring long term ventilation, increase in the number of premature birth and the emergence of the COVID-19 pandemic are the factors driving the market growth.
Factors like escalation of AI as a medical device, increasing prevalence of chronic, communicable diseases and escalating geriatric population and the increasing trend of acquisitions, collaborations, investments in the AI in healthcare market are further substantiating the enormous growth opportunities of the market
The factors driving the genomics market are demand for early disease detection, diagnosis, and treatment, rising government and private funding, increasing awareness and reduced cost of genomics test, favorable reimbursement, increasing demand for personalized medicine, increasing utilization of genomic technologies in drug discovery & development and technological advancements.
Some of the factors driving the market are increase in incidence and prevalence of neurovascular diseases like cerebral aneurysm, stroke, arteriovenous malformations, and increase in the aging population, technological advancement, acquisitions and favourable reimbursements.
This report covers all segments, global trends and emerging strategies of the outsourcing market related to drug discovery, preclinical development, clinical phases and commercial manufacturing of biologics.
Technological advancements in cell line engineering (gene editing tools) & cell line development technologies, screening technologies and process development are giving immense growth opportunities for the market
IQ4I
Latest News
An increase in the adoption of minimally invasive surgeries, rapid growth in the aging population, growing number of cosmetic surgeries, the prevalence of obesity and its related surgeries, the advancement in technology, and demand for electrosurgical procedures in emerging regions are driving the growth....
IQ4I
Clientele
Offering solutions to >500 clients from the U.S., Europe, Japan, Korea, Singapore and Australia in realizing the market potential and competitive intelligence across healthcare domains (Medical Technologies, Pharmaceutical, Biotech and Life Sciences).
